Skip to main content
. Author manuscript; available in PMC: 2011 May 15.
Published in final edited form as: J Immunol. 2010 Apr 9;184(10):5612–5618. doi: 10.4049/jimmunol.0903549

Figure 5. Isolation and in vitro activation of Thy1.1+/CD4+ memory cells.

Figure 5

A. Spleens were harvested 276 days after adoptive transfer 4×107 Thy1.1+/CD62Llow/CD4+ effector T cells to tumor-free Thy1.2 mice. Thy1.2+ cells were depleted, and the negative fraction was separated into TCM (CD62Lhigh) and TEM (CD62Llow) subsets with MACS columns before culture activation. The percentage of Thy1.1+ TEM or TCM is indicated on the right of the dot-plot quadrants. B. On days 2, 7, 14 of culture, Thy1.1+ cells in each subset further were purified using MACS columns and on day 14, CD8+ T cells were depleted. At the completion of the in vitro activation with anti-CD3/IL-2/IL-7, cultures originally derived from TCM or TEM cells were analyzed for purity and phenotype.